According to Friday's announcement, the transplant was performed on 10 patients, and no major safety issues were confirmed.
Tokyo startup confirms efficacy of iPS cell-derived heart muscle transplants
Published 2 days ago
Source: japantimes.co.jp
Categories
JAPAN
Related Articles from japantimes.co.jp
24 minutes ago
Sabalenka named WTA Player of the Year for second straight season
25 minutes ago
EU to relent on combustion engines ban after auto industry pressure
1 hour ago
Ford retreats from EVs and takes $19.5B charge as Trump policies take hold
1 hour ago
Sydney mourns 15 killed in Australia's worst mass shooting in nearly 30 years
1 hour ago
U.S. dangles security guarantees for Ukraine but no deal on 'painful' territorial concessions
3 hours ago